ACLX
Price
$60.70
Change
-$4.90 (-7.47%)
Updated
Apr 1 closing price
Capitalization
3.34B
36 days until earnings call
ADMA
Price
$19.40
Change
-$0.44 (-2.22%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
4.61B
35 days until earnings call
Ad is loading...

ACLX vs ADMA

Header iconACLX vs ADMA Comparison
Open Charts ACLX vs ADMABanner chart's image
Arcellx
Price$60.70
Change-$4.90 (-7.47%)
Volume$1.06M
Capitalization3.34B
ADMA Biologics
Price$19.40
Change-$0.44 (-2.22%)
Volume$47.51K
Capitalization4.61B
ACLX vs ADMA Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. ADMA commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and ADMA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ACLX: $60.70 vs. ADMA: $19.84)
Brand notoriety: ACLX and ADMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 171% vs. ADMA: 148%
Market capitalization -- ACLX: $3.34B vs. ADMA: $4.61B
ACLX [@Biotechnology] is valued at $3.34B. ADMA’s [@Biotechnology] market capitalization is $4.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileADMA’s FA Score has 2 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • ADMA’s FA Score: 2 green, 3 red.
According to our system of comparison, ADMA is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while ADMA’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 6 bearish.
  • ADMA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ADMA is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -15.88% price change this week, while ADMA (@Biotechnology) price change was -2.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

ACLX is expected to report earnings on May 08, 2025.

ADMA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($4.61B) has a higher market cap than ACLX($3.34B). ADMA YTD gains are higher at: 15.685 vs. ACLX (-20.850). ADMA has higher annual earnings (EBITDA): 98.8M vs. ACLX (-99.06M). ACLX has more cash in the bank: 587M vs. ADMA (86.7M). ACLX has less debt than ADMA: ACLX (54.1M) vs ADMA (111M). ADMA has higher revenues than ACLX: ADMA (383M) vs ACLX (108M).
ACLXADMAACLX / ADMA
Capitalization3.34B4.61B72%
EBITDA-99.06M98.8M-100%
Gain YTD-20.85015.685-133%
P/E RatioN/A23.98-
Revenue108M383M28%
Total Cash587M86.7M677%
Total Debt54.1M111M49%
FUNDAMENTALS RATINGS
ADMA: Fundamental Ratings
ADMA
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
11
SMR RATING
1..100
27
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXADMA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 9 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GAA29.120.25
+0.86%
Cambria Global Asset Allocation ETF
HTRB33.860.07
+0.21%
Hartford Total Return Bond ETF
FSLD50.200.04
+0.07%
Fidelity Sustainable Low Dur Bd ETF
DFEN30.70-0.09
-0.29%
Direxion Dly Aerospace&Def Bl 3X ShsETF
CCD21.29-0.15
-0.70%
Calamos Dynamic Convertible & Income Fund

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with ATRA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-2.07%
ATRA - ADMA
44%
Loosely correlated
-9.04%
TARS - ADMA
40%
Loosely correlated
-0.72%
RCUS - ADMA
37%
Loosely correlated
-3.92%
LOGC - ADMA
36%
Loosely correlated
+0.43%
ACLX - ADMA
36%
Loosely correlated
-3.47%
More